Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow margin | 12.2% | 5.7% | 7.2% | 11.9% | 13.4% | 17.7% | 20.9% | 21.1% | 36.3% | 18.4% | 16.5% | 6.1% | 8.4% | 20.3% | 22.1% | 27.7% | 31.3% | 32.8% | 25.9% | 28.1% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Free Cash Flow margin is 29.1%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Free Cash Flow margin for Bristol-Myers Squibb Company have been 28.4% over the past three years, and 30.6% over the past five years.
As of today, Bristol-Myers Squibb Company's Free Cash Flow margin is 29.1%, which is higher than industry median of 19.1%. It indicates that Bristol-Myers Squibb Company's Free Cash Flow margin is Good.